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Abstract
Research on genetically engineered mice provides insights into the etiology, therapy, and genetic basis of
human diseases. An important variable that affects the results of mouse studies is the health status of
the animals. Pathogen burdens may confound observations and obscure underlying mechanisms. Mouse
resource centers frequently rederive infected mouse strains. We review our experience on the use of a
well-established technique, embryo transfer to rederive infected mouse strains. The following mouse
pathogens were eliminated by embryo transfer: Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Rota-
virus, Mouse Encephalomyelitis Virus, Mouse Adenovirus, Helicobacter species, endoparasites, and ecto-
parasites. We rederived transgenic mouse lines, gene-targeted mouse lines, and lines with spontaneous
mutations. In the majority of strains, fertilized eggs for embryo transfer were obtained by mating supe-
rovulated egg donors with males of the desired genotype. A total of 309 embryo transfers were per-
formed to rederive 96 mouse strains. The pregnancy rate was 76%; 1996 pups were born, of which 43%
carried the desired genotype. We performed 44 additional embryo transfers to rederive 15 other strains.
The pregnancy rate was lower (45%) and none of the 135 pups carried the desired genotype. Although
we successfully eliminated the pathogens in all transfers, we were unable to obtain pups with the desired
genotype in 15 of 111 mouse lines. Multiple factors affect the efficiency of rederivation by embryo trans-
fer. They include the response to superovulation by embryo donors, the number and age of stud males,
the yield of fertilized eggs, the number of embryo transfers, and genotyping.
Introduction
Use of genetically engineered mice to understand
human disease processes is increasing. It is
important that these studies are conducted in spe-
cific pathogen free (SPF) mouse models. Animals
need to be free of pathogen infections if physio-
logical changes attributed to genetic alterations
are to be extrapolated to other species. If the
mouse models are pathogen infected their
response to infection may mask genetic changes
and/or complicate the interpretation of results.
Viral, bacterial, and parasitic infections can inter-
fere with research results in animal models
(National Research Council, 1991, reviewed in
Homberger et al., 1999). Consequently, it is fre-
quently desirable to rederive mouse stocks to
SPF status. This is often required to import ani-
mals into clean barrier facilities, to replace
populations after a spontaneous infection of
unknown etiology, or to eliminate pathogens that
may interfere with research. We have extensive
experience in pathogen free rederivation of mouse
stocks. In our hands, the use of embryo transfer
is a reliable and effective method of rederivation.
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The pathophysiological response to infection
may obscure the consequences of genetic altera-
tions. For example, viral infections cause immune
system dysfunction (Jacoby et al., 1996; Homber-
ger 1997). In addition to provoking physiological
changes, the clinical presentation of viral infec-
tions can mimic phenotypes caused by experi-
mental genetic changes in mice. For example,
hindlimb paralysis occurs in alpha A-crystallin
transgenic mice (De Rijk et al., 2000) and in mice
infected with Murine Hepatitis Virus (MHV)
(Glass et al., 2002) or Theilers Mouse Encephalo-
myelitis Virus (TMEV) (Tsunoda et al., 1996). In
some cases, an infection is responsible for pro-
ducing a phenotype in a gene-targeted mouse
that would otherwise appear normal. Engle et al.
(2002) reported that double mutant mice for
Tgfb1 and Rag2 develop colitis and colon cancer
if they are infected with Helicobacter hepaticus
but remain free of inflammatory lesions and car-
cinoma in the absence of H. hepaticus organisms.
Sensitive behavioral tests are also influenced by
experimental viral infections. Reduced activity in
open-field behavior tests occurred in v-Ha-ras
transgenic mice (Colombo et al., 2000) and in
mice experimentally infected with human influ-
enza virus (Shi et al., 2003). Just as the presence
of a pathogen can induce a phenotypic alter-
ation, so can the treatment of mice for parasites.
A common approach to pinworm infection is to
treat mice with the anti-helmitic drug Ivermectin.
Paradoxically, although this treatment effectively
eliminates pinworm and its consequences, Iver-
mectin treatment alters the outcome of mouse
behavior tests (Davis et al., 1999). Research on
physiological changes attributed to experimen-
tally induced genetic changes needs to be distinct
from changes induced by pathogen infections.
Careful health assessment of these animals is
required to determine whether changes are due to
genetic manipulation.
Rederivation of pathogen-infected mice by
embryo transfer to pathogen free recipients is an
effective method of disease elimination. Reetz
et al., (1988) eliminated MHV and Pasteurella
pneumotropica from six inbred strains. Morrel
(1999) reported the elimination of MHV, rotavirus
(Epizootic Diarrhea of Infant Mice Virus: EDIM),
reo-3 virus, TMEV, and Mouse Adenovirus
(MAD). Selecting embryos with intact zona pellu-
cida (z.p.) for embryo transfer is important
because the z.p. prevents contact between infec-
tious viral particles and the cell membrane. Incu-
bation of eggs with and without z.p. in Mouse
Parvovirus (MPV) suspensions demonstrated that
the z.p. prevents infection from occurring (Moh-
anty & Bachman, 1974). Similarly, both Reetz
et al. (1988) and Carthew et al. (1985) incubated
embryos with or without z.p. in MHV suspensions
and observed that the z.p. prevents MHV infec-
tion. Indirect evidence suggests that the z.p. also
protects embryos from TMEV since inoculation of
pregnant female mice with the virus on days 1–3 of
gestation (while preimplantation embryos are pro-
tected by the z.p.) does not result in virus positive
fetuses although positive fetuses are found when
virus is inoculated on gestational days 4 and 5
(after the z.p. is shed) (Abzug & Tyson, 2000). Hill
and Stalley (1991) showed that Mycoplasma pul-
monis could be eliminated from z.p. intact eggs by
overnight culture in mouse embryo media, which
does not support M. pulmonis growth. Serial dilu-
tion of preimplantation embryos collected from
infected mice reduces the concentration of infec-
tious organisms below the threshold of infection in
the transfer fluid (Stringfellow, 1998). As a conse-
quence, pups, born after transfer of washed
embryos to SPF surrogate mothers, enjoy the
same pathogen free status as their mothers.
We summarize our results on the effectiveness
of mouse embryo transfer to rederive 111 geneti-
cally altered mouse strains with enzootic pathogen
infections. Our results confirm the elimination of
MHV, EDIM, TMEV, and MAD by embryo
transfer. In addition, we show that this method
effectively eliminates MPV, Helicobacter spp.,
M. pulmonis, endoparasites (pinworm), and ecto-
parasites (fur mites). We discuss our success rate
and the factors that influence it. We compare
embryo transfer rederivation with alternatives.
Methods and materials
Animals
Adult (6 weeks to 6 months old) (C57BL/6J X
DBA/2J) F1 male and female mice were obtained
from the Jackson Laboratory (Bar Harbor,
Maine). Adult CD-1 male and female mice were
obtained from Charles River Laboratory
(Wilmington, Delaware). We used CD-1 mice to
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produce pseudopregnant recipients until year
2000 and used (C57BL/6J X DBA/2J)F1 mice
since then. Vasectomized males were housed one
per cage and females were housed five per cage
prior to embryo transfer. Vasectomized males
were mated randomly with two or three females
naturally cycling through estrus to produce pseu-
dopregnant recipients for embryo transfers.
Weanling (3 weeks old) egg donors (C57BL/6J,
C3H/HeJ, DBA/2J, and 129S1/SvlmJ) were
obtained from the Jackson Laboratory. Egg
donors were superovulated and mated with
infected males to produce fertilized mouse eggs.
If there was a need to maintain the unique mixed
genetic background of a mouse strain then both
egg donors and stud males were obtained from
the infected mouse colony. Static microisolater
caging (Allentown Caging, Allentown, New Jer-
sey) and ground corncob bedding were used for
all animals. Access to water and food was ad lib-
itum. The animals were fed Purina 5008 rodent
diet. Animal rooms were climate controlled to
provide temperatures of 22–23C and relative
humidity of 15% on a 12-h light/dark cycle
(lights on at 0600). All procedures were
approved by the University of Michigan Com-
mittee on Use and Care of Animals. Animal care
was provided in accordance with the principles
and procedures outlined in the National
Research Council Guide for the Care and Use of
Laboratory Animals.
Egg collection and washing
Superovulation was used to increase the numbers
of eggs per donor and to reduce the total number
of egg donors required. At 15:00, egg donors
were injected intraperitoneally with 5 I.U. preg-
nant mare’s serum gonadotropin obtained from
the National Hormone and Peptide Program
(National Institute of Diabetes and Digestive and
Kidney Diseases). After 46 h, egg donors were
injected intraperitoneally with 5 I.U. of human
chorionic gonadotropin (HCG, Sigma Chemical
Company). After HCG treatment, egg donors
were taken from their pathogen free mouse room
to the quarantine room and singly mated with
infected stud males. Whenever possible, 3–6
males were mated so that there were enough fer-
tilized eggs for transfer to multiple recipients.
The following morning (09:00–11:00) egg donors
were euthanized in the quarantine room and sub-
merged in 3.3% bleach during transportation to
the egg collection laboratory (5–8 mins). This
treatment is expected to inactivate viruses, bacte-
ria, parasites and their eggs (D. Ringler, personal
communication). The eggs were stripped of
cumulus granulosa cells by hyaluronidase treat-
ment as described (Hogan et al. 1994). Fertilized
eggs with intact zona pellucida were selected for
subsequent washing and transfer. Eggs were
sequentially washed five times in 1.0 ml drops of
sterile M2 medium (Sigma Chemical Co., St.
Louis, Missouri) with changes of sterile transfer
pipets between drops. Eggs were washed through
four drops of 0.075 ml C02 equilibrated BOMC
medium (Invitrogen, Carlsbad, California) sup-
plemented with 5000 I.U./ml penicillin and strep-
tomycin (Invitrogen) with transfer pipet changes
between drops. The eggs were incubated in
BOMC at 37C, 5% C02, 95% relative humidity
until surgical transfer. The washing steps diluted
the original volume of fluid containing the eggs
by a factor of 1 · 1021, which exceeds the
1 · 1020 dilution, recommended by the Interna-
tional Embryo Transfer Society (Stringfellow,
1998). For the elimination of Mycoplasma pulmo-
nis, embryos were incubated overnight and trans-
ferred the following day (Hill & Stalley, 1991).
Embryo transfer and genotyping
Pseudopregnant females were identified by the
presence of a copulation plug after mating with
vasectomized males. Embryo recipients were
anesthetized with ketamine/xylazine as described
by Zeller et al. (1998). Egg transfer into oviducts
was performed as described in Hogan et al.
(1994). Each recipient received 20–25 one-cell egg
divided between the two oviducts. When eggs
were cultured overnight, 16–20 two-cell eggs were
divided between the oviducts. Recipients were
housed one or two per cage. When pups were
2 weeks of age, they were ear tagged (National
Band and Tag, Newport, Kentucky) for tracking
purposes and 5-mm tail tip biopsies were col-
lected for DNA extraction. Each DNA sample
was genotyped by a PCR assay for a specific
transgene or targeted gene. All genotyping assays
were performed by the research laboratories that
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submitted animals for rederivation. When a
genetic test was unavailable for the desired
genetic background, offspring were bred to verify
the transmission of the desired phenotype. This
was often the case for mouse strains carrying
spontaneous mutations that were molecularly un-
characterized or for which the genetic etiology
had not been established.
Pathogen testing
Serum samples were collected from dams
6–8 weeks after the embryo transfer procedure.
Immuncomb tests (Charles River Laboratory)
were used on site (University of Michigan Unit
for Laboratory Animal Medicine) to detect anti-
bodies to MHV, Sendai virus, and Mycoplasma
pulmonis. Cecal flotation was used to detect the
presence of Aspicularis tetraptera (pinworm).
Myobia musculi (fur mites) were detected by exam-
ining skin and fur. All other assays (MPV, EDIM,
TMEV (GDVII), MAD, and Helicobacter spp.)
were performed offsite as part of Health Assess-
ment Plus testing at Charles River Laboratories.
Criteria for success
Three criteria were used to determine whether a
mouse strain was successfully rederived as a SPF
mouse line. (1) Viable animals of the desired
genotype were produced. For transgenic or gene-
targeted mouse strains crossed to standard inbred
mouse lines, at least one male or female pup with
the transgene was produced. For strains in mixed
genetic backgrounds, at least one male and one
female pup were produced to establish a breeding
pair. (2) Embryo recipients were pathogen free
6–8 weeks after embryo transfer. (3) Subsequent
surveillance of pups and their offspring demon-
strated they continued to be pathogen free.
Results
MHV elimination
Over a 3-year period 42 embryo transfers were
performed to successfully eliminate MHV from
nine mouse strains backcrossed to C57BL/6 (two
gene-targeted and seven transgenic lines). Fertil-
ized eggs were obtained for transfer by mating
pathogen free C57BL/6 females with infected
stud males. In the successful rederivations, 81%
of the embryo recipients became pregnant and
delivered an average of seven pups (Table 1).
MHV was eliminated in every case; however,
pups with the desired genotype were not obtained
from three strains.
MPV elimination
Over a 2-year period, 77 embryo transfers were
performed to eliminate MPV from 47 mouse
strains. One of these was a gene-targeted strain on
a mixed 129/Sv genetic background, the other 46
were transgenic strains backcrossed to C57BL/6.
Fertilized eggs were obtained by mating commer-
cially procured pathogen-free C57BL/6 females to
infected transgenic males. In order to maintain the
unique mixed genetic background of the gene-
targeted strain, infected embryo donors were supe-
rovulated and mated with infected stud males to
obtain fertilized eggs. In the successful rederiva-
tions, 84% of the embryo recipients became preg-
nant and delivered an average of 10 pups
(Table 2). MPV was eliminated in every case; how-
ever, pups with the desired genotype were not
obtained from nine of the mouse strains.
Elimination of Helicobacter species
We rederived two mouse strains that were
infected with Helicobacter species, as detected by
diagnostic testing at Charles River Laboratory.
Table 1. Mouse hepatitis virus elimination by mouse embryo transfer






Number of pups born Pups with desired
genotype
C57BL/6J 9 42 34 (81%) 252 102 (40%)
Unsuccessful rederivation attempts
C57BL/6J 3 16 7 (44%) 41 0 (0%)
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One strain was a transgenic line on a mixed
genetic background and the other was a sponta-
neous mutation in C57BL/6. In order to maintain
their unique genetic backgrounds, infected
embryo donors were superovulated and mated
with infected stud males to obtain fertilized eggs
for embryo transfer for both strains. Fertilized
eggs were transferred to 12 recipients resulting in
six pregnancies. A total of 48 pups were born.
Since egg donors and male studs were from the
same genetic background, all of the pups born
carried the desired genotype. Thus, embryo trans-
fer succeeded in the rederivation of both mouse
strains that were positive for Helicobacter species.
Elimination of pinworm
We rederived three mouse strains with pinworm
(Aspicularis tetraptera) infections, as diagnosed
by flotation of cecal contents. One was a gene-
targeted strain backcrossed to 129S1/SvImJ: the
second was a gene-targeted strain backcrossed to
C57BL/6 and the third was a transgenic strain
backcrossed to C57BL/6. Fertilized eggs were
transferred to 19 recipients resulting in sixteen
pregnancies (84%) (Table 3). A total of 127 pups
were born for an average of eight pups per dam;
51 of the pups had the desired genotype. Thus,
embryo transfer successfully eliminated pinworm
infections in all three lines.
Combined MHV, EDIM, and mite infections
We performed 154 embryo transfers to rederive 32
mouse strains that were infected with two viruses
and an ectoparasite (Table 4). The founder colo-
nies were seropositive for MHV and EDIM. In
addition, inspection of pelage demonstrated the
Table 2. Mouse parvovirus elimination by mouse embryo transfer










C57BL/6J 46 72 61 (85%) 610 225 (37%)
Mixed 1 5 4 (80%) 55 36 (65%)
Combined Total 47 77 65 (84%) 665 261 (39%)
Unsuccessful rederivation attempts
C57BL/6J 9 17 12 (71%) 93 0 (0%)
Table 3. Mouse pinworm elimination by mouse embryo transfer










C57BL/6J 2 12 11 (92%) 80 32 (40%)
129S1/SvlmJ 1 7 5 (71%) 47 19 (40%)
Combined total 3 19 16 (84%) 127 51 (40%)
Table 4. Multiple pathogen elimination by mouse embryo transfer










C57BL/6J 28 138 98 (71%) 865 403 (47%)
C3H 1 6 3 (50%) 18 10 (56%)
CD-1 1 3 2 (67%) 11 5 (45%)
Mixed 2 7 6 (86%) 58 25 (43%)
Combined total 32 154 109 (71%) 952 443 (46%)
Unsuccessful rederivation attempts
DBA/2 2 8 1 (12%) 1 0 (0%)
Mixed 1 3 0 (0%) 0 0 (0%)
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presence of fur mites. Twenty-eight strains were
backcrossed to C57BL/6, 15 were transgenic, nine
were spontaneous mutations, and four were gene-
targeted strains. One strain was a spontaneous
mutant backcrossed to C3H/HeJ, one was a trans-
genic on the CD-1 background and two were a
spontaneous mutants on mixed genetic back-
grounds. In order to maintain their unique genetic
backgrounds, infected embryo donors from mixed
genetic backgrounds were superovulated and
mated with infected stud males to obtain fertilized
eggs for embryo transfer. In the successful rederi-
vations, 71% of the embryo recipients became
pregnant and delivered an average of nine pups
(Table 4). All three pathogens were eliminated in
each case; however, no pups of the desired geno-
type were obtained from three strains.
Combined MHV, MPV, EDIM, MAD, GDVII,
mycoplasma and pinworm infection
We rederived three mouse strains that were
infected with multiple pathogens: MHV, MPV,
EDIM, MAD, GDVII, Mycoplasma pulmonis,
and pinworm. These three transgenic lines were
on unique mixed genetic backgrounds so that
infected embryo donors were superovulated and
mated with infected stud males to obtain fertilized
eggs for embryo transfer. We collected the eggs
and cultured them overnight to eliminate infec-
tious mycoplasma (Hill & Stalley ,1991) prior to
embryo transfer. Cleavage eggs that developed
normally were transferred to five recipients. All
five recipients became pregnant and 27 pups were
born. Since the egg donors and male studs were
both from the same mixed genetic background,
all of the pups born carried the desired genotype.
Because of the complex pathogen load in these
mice, dams were sent to Charles River Labora-
tory for health assessment plus tests that showed
the animals were pathogen free.
Discussion
We established a mouse pathogen rederivation
program based on embryo transfer and show
that it is effective for the elimination of mouse
viral, bacterial, and parasitic infections. A total
of 96 independent mouse strains were successfully
rederived. Our embryo transfer procedures
eliminated every mouse pathogen that we
encountered and attempted to eradicate: MHV,
MPV, EDIM, TMEV (GDVII), MAD, Helicob-
acter spp., Mycoplasma pulmonis, pinworm and
fur mites. Although this is not a comprehensive
list of all mouse pathogens, we eliminated three
categories of organisms: viruses, bacteria, and
parasites. It is likely that the application of
embryo transfer to the rederivation of other
mouse pathogens, such as protozoa, will be
equally successful. Embryo transfer eliminates
organisms from the environment of the preim-
plantation embryo by extensive washing in sterile
media. Consequently, the pups that are born
have the same health status as their surrogate
mothers. In agreement with this, it was demon-
strated that germ free mouse lines can be success-
fully derived by embryo transfer to germ free
surrogate mothers (Okamoto & Matsumoto,
1999). We conclude that embryo transfer is an
efficient method for the pathogen free rederiva-
tion of infected mouse lines.
We observed that in all embryo transfer recip-
ients, pathogens were eliminated whether egg
donors were obtained from an enzootically
infected founder colony or imported from a com-
mercial vendor. When we mated heterozygous
transgenic or gene-targeted stud males to wild
type egg donors, we expected half the pups to
have the desired genotype. In the successful re-
derivation procedures, we observed that 857
(43%) of the 1996 pups born carried the desired
genotype. This is fewer than expected
(p < 0.005, v2 Test). The reasons for this lower
than expected frequency of pups with the desired
genotype is unclear. It may the result of technical
problems (insensitive genotyping assays) or the
reduced viability of genetically engineered pups.
In addition to the 96 successful rederivations,
we were unable to rederive 15 mouse lines. These
were characterized by the failure to identify rede-
rived pups of the desired genotype and not by
the failure to eliminate pathogens. Factors that
reduced the efficiency of embryo transfer rederi-
vation in the 15 unsuccessful attempts can be
divided into logistical problems: e.g. only one
stud male available for embryo production and
biological problems, e.g. inefficient production of
fertilized eggs for embryo transfer. The principle
difference between successful and unsuccessful re-
derivation procedures was the availability of four
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or more stud males with good reproductive per-
formance. On several occasions, replacement of
stud males older than 6 months with young ani-
mals changed unsuccessful attempts to successful
ones. Initial compliance by laboratories to pro-
vide 4–6 stud males in prime reproductive condi-
tion minimized the time to complete successful
rederivations. Of the 15 rederivations that did
not produce pups with the desired genotype, nine
depended on a single stud male, three depended
on old males (>8 months) and three others
depended on the use of strains that did not pro-
duced fertilized eggs in response to superovula-
tion and stud mating (one mixed background
and DBA/2). Another possible factor is the sensi-
tivity and accuracy of genotyping assays, which
we did not perform and thus are unable to
assess. Similarly we are unable to directly assess
the effects of genetic manipulations on prenatal
viability of the transferred embryos. Additional
studies are necessary to address this issue.
Factors that affect the success of embryo
transfer can be divided into three areas: (1) tech-
nical competency in surgery, (2) production of
fertilized eggs for transfer, (3) selection of surro-
gate mothers and appropriate husbandry, and (4)
the sensitivity of genotyping assays to detect the
desired genotype. The first, third, and fourth fac-
tors are easily controlled by providing training to
staff and by selecting outbred or vigorous hybrid
female recipients. The single most critical factor
in post-surgery husbandry to maintain pregnancy
and establish lactation is provision of appropri-
ate rodent diet, containing 6.0–6.5% fat. Preg-
nancy and post-partum survival is severely
reduced in surrogate dams fed diet containing
4.5% fat (T. Saunders, unpublished observa-
tions). The second factor, production of fertilized
eggs, depends on biological factors that are not
always under control of the investigator. For
example, some inbred strains respond poorly to
superovulation treatments (Spearow, 1988) and
produce few eggs for fertilization. Other inbred
strains, such as PL/J have poor sperm quality
that affect numbers of fertilized eggs (Pyle &
Handel, 2003; T. Saunders, unpublished observa-
tions). A less quantifiable factor is embryo sensi-
tivity to experimental manipulation. In
particular, DBA/2 rederivation is consistently dif-
ficult due to low birth rates after embryo transfer
(Table 4 and unpublished observations). Trans-
genic offspring are generally identified by PCR
reactions that detect unique DNA sequences in
the transgene. Our experience with numerous
research laboratories indicates that genotype
assignations are conservative, designed to exclude
borderline results and to accept only robust posi-
tive reactions. Routine fluctuations in PCR
assays can affect genotyping accuracy, particu-
larly in the absence of rigorous quality control
procedures. Factors that affect genotyping repro-
ducibility include: (1) extraction of pure DNA
from tail tip biopsies, (2) determination of the
limit of PCR sensitivity (does the assay detect
transgene DNA with single copy gene equiva-
lency?), (3) appropriate positive and negative
controls to demonstrate that mouse DNA is pres-
ent in the assay, and (4) the absence of transgene
DNA contamination. The majority of mouse re-
derivations proceed smoothly and successfully
when all of these variables are controlled.
In the few cases, where mice are not rederived
by embryo transfer the most common problem is
obtaining fertilized eggs for embryo transfer. Often
this is resolved by increasing the number of stud
males to four and/or replacing old stud males with
animals in their reproductive prime (2–6 months
old). If this does not result in fertilized eggs then
alternative methods to obtain fertilized eggs
include: in vitro fertilization (IVF), natural mating,
and intracytoplasmic sperm injection (ICSI). IVF
procedures can yield hundreds of fertilized eggs for
embryo transfer from a single procedure with
sperm pooled from a few males (Thornton et al.,
1999). Suzuki et al. (1996) successfully eliminated
MHV and Pasteurella pneumotropica with IVF fol-
lowed by embryo transfer. Fewer eggs are pro-
duced by natural mating than by superovulation.
The need for several females to ovulate spontane-
ously at the same time increases the number of ani-
mals required for fertilized egg production by
natural mating. If natural mating is not effective
due to low sperm counts then ICSI can be used
because few individual sperm are needed to pro-
duce fertilized eggs by this method. This approach
may not be suitable when specific genetic back-
grounds must be rederived because ICSI is signifi-
cantly less efficient in inbred strains than in hybrid
strains (Kawase et al., 2001). The alternative to re-
derivation by embryo transfer is rederivation by
hysterectomy. This approach can be used with
strains of very low male and female fertility or for
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mouse embryos that do not survive well in culture.
Hysterectomy relies on the production of synchro-
nized pregnancies between the strain undergoing
rederivation and an SPF mouse colony that is used
for fostering pups. The disadvantages include the
loss of viable pups during hysterectomy, the
increased probability of infecting pups or surro-
gate mothers during the procedure, the elimination
of pups from the SPF litter, and the loss of pups
ignored by SPF surrogates. Although animal-
intensive hysterectomy may be indicated when
other rederivation procedures are ineffective.
In the context of animal welfare principles
(Flecknell, 2002) pathogen rederivation offers
refinement of experimental design by reducing pain
and distress. It can be anticipated that healthy,
SPF mice will more faithfully reflect physiological
changes due to genetic alterations than diseased
mice. This, in turn, can reduce variability in experi-
mental groups and the number of animals needed
to draw statistically meaningful conclusions. In
comparison to other methods, embryo transfer
rederivation reduces the number of animals
required for rederivation. In the average rederiva-
tion procedure, we used four superovulated egg
donors. IVF and ICSI procedures often require
10–20 females per procedure. Hysterectomy
requires multiple synchronized litters of infected
and SPF mice. Some pups from infected litters do
not survive the procedure and pups are lost from
SPF litters when they are replaced by rederivation
pups. As a consequence, hysterectomy is the most
animal intensive rederivation procedure.
Embryo transfer is an effective method to
eliminate pathogens from genetically engineered
mouse strains. The study of pathogen free ani-
mals eliminates the confounding effects of patho-
gen infection from research results. Further
studies are needed to determine if lower than
expected transmission ratios of transgenes and
mutant alleles are due to inaccurate genotyping
assays or reduced embryo survival. Future direc-
tions include the wider application of this
method to additional pathogens and to the estab-
lishment of germ free mouse strains.
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